Status
Conditions
Treatments
About
Several experiences of multidisciplinary care pathways associating oncologists, pharmacists and nurses have been reported for cancer patients, with positive results on medication management safety, reduction of Drug-Related Problems (DRPs), and re-hospitalizations.
This study aims to evaluate the impact of a multidisciplinary city-hospital follow-up program on medication management safety in haematological oncology patients receiving intravenous chemotherapy in onco-haematology. Additional aspects will be evaluated, such as the impact of the follow-up on the city-hospital link, satisfaction of patients and professionals involved in the follow-up and the use of telecare
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adult patients aged 18 years or older With hematological malignancy at any stage Initiating R-CHOP or G-CHOP chemotherapy Who do not object to participation in the study and use of collected data
Exclusion criteria
Patients already enrolled in a clinical trial evaluating any drug product
Patients living in an institution
Patients protected by law
38 participants in 1 patient group
Loading...
Central trial contact
Catherine RIOUFOL, Pr.; amandine baudouin, Dr
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal